What Pharma 5 does

Pharma 5 is a Morocco-based pharmaceutical company founded in 1985 and headquartered in Casablanca. According to firmographic data, it provides generic drug development and manufacturing services, operating as a private for-profit entity with a workforce of 251-500 employees. The company's geographic footprint extends beyond its Moroccan base into Southern Africa, where it has supplied pharmaceutical products to the South African state market as a participant in government tenders.

Business model specifics (pricing, product mix, distribution channels, customer segments) are not disclosed in the available source data, and the company's website (pharma5.ma) currently presents only a hosting-provider default page rather than active corporate content. No management team, partnerships, funding rounds, products-and-services catalog, certifications, or financial figures are documented in the provided sources.

The company has recently been drawn into a regulatory matter: South Africa's Competition Commission launched an investigation into Pharma 5 alongside Ascendis, Pharma Q, and Sonke following a complaint from the South African health department, with the probe reportedly at an early stage. The companies under investigation stated they were unaware of the action. Ownership, corporate structure, and detailed operating metrics for Pharma 5 remain undisclosed in the input data, representing material information gaps for any investment assessment.

Name

Pharma 5

Website

https://pharma5.ma

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

Keywords

• Generic pharmaceuticals
• Drug manufacturing
• Pharmaceutical products
• Generic medications
• Pharmaceutical development

Headquarters

HQ city

Casablanca

HQ country

Morocco

HQ region

Africa

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D

Core offering

Pharma 5 is a pharmaceutical company that develops and manufactures generic drugs. Based in Casablanca, Morocco and founded in 1985, the company produces pharmaceutical products, with operating reach extending into Southern African markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Generic drug development and manufacturing

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights2 records

Broad incumbents

• Sun Pharmaceutical Industries: India's largest pharmaceutical company, which owns Sonke Pharmaceuticals in South Africa — one of the entities co-investigated with Pharma 5 by the South African Competition Commission. Directly comparable as a generics manufacturer with African distribution.
• Cipla: Indian-headquartered global generic powerhouse with a long-standing focus on African markets, including HIV/AIDS and respiratory therapies. Comparable to Pharma 5 as a generic drug supplier competing in African public-sector procurement.
• Sanofi: Global pharmaceutical major with an established generics and vaccines business in Africa, including partnerships with African manufacturers. Comparable to Pharma 5 as a participant in African generic drug supply, though broader in scope and scale.

Direct peers

• Aspen Pharmacare: Largest South African generics and specialty pharma manufacturer, supplying both private and public-sector African markets. Highly comparable to Pharma 5 as a regionally focused generic manufacturer competing for the same African state-tender contracts.
• Strides Pharma International: India-based generic pharmaceutical manufacturer with a deliberate focus on emerging markets including Africa. Comparable to Pharma 5 in business model (generic drug development and manufacturing) and target geography.
• Hikma Pharmaceuticals: MENA-headquartered generic and specialty pharmaceutical manufacturer with established operations across the Middle East and Africa. Comparable to Pharma 5 as a generics-focused manufacturer operating across African and adjacent emerging markets.
• Micro Labs: Indian generic manufacturer identified in the available data as part-owner of Pharma Q, a co-investigated entity with Pharma 5. Comparable as a generics manufacturer supplying the African public-sector market.
• Adcock Ingram: South African pharmaceutical manufacturer with a significant generics and OTC portfolio serving the public and private healthcare sectors. Comparable to Pharma 5 as a domestic-to-regional African generic drug manufacturer.
• Ascendis Health: South African healthcare company with branded generics and OTC operations, named alongside Pharma 5 in the Competition Commission probe. Comparable as a regional generics competitor in the Southern African market.

Regional players

• Julphar (Gulf Pharmaceutical Industries): UAE-based generics manufacturer with a strong MENA footprint and growing African presence. Comparable to Pharma 5 as a regional generics manufacturer targeting emerging markets, though primarily operating in a different geographic footprint.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/pharma5officiel
• Facebookfacebook.com/Pharma5Officiel
• LinkedInlinkedin.com/company/pharma-5-officiel

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma 5